HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neutralizing antibodies after infection with dengue 1 virus.

Abstract
Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1 at an interval of 20 years. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with severity of a second infection. If this mechanism controlled disease severity in Cuba, heterotypic antibody titers should have declined over time. To determine whether phenotypic changes in dengue antibodies occur over time, we analyzed serum samples collected 4-8 and 20-22 years after DENV-1 infection. We found a significant increase in mean titer of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to 1 of 2 genotypes of DENV-2 virus (the American genotype). Asian DENV-2 viruses were not neutralized during either interval; however, the American genotype underwent phenotypic changes in heterotypic viral neutralizing antibodies in the predicted direction. This finding may be related to the time-dependent changes in severity of disease found with secondary dengue infection.
AuthorsMaria G Guzman, Mayling Alvarez, Rosmari Rodriguez-Roche, Lidice Bernardo, Tibaire Montes, Susana Vazquez, Luis Morier, Angel Alvarez, Ernest A Gould, Gustavo Kouri, Scott B Halstead
JournalEmerging infectious diseases (Emerg Infect Dis) Vol. 13 Issue 2 Pg. 282-6 (Feb 2007) ISSN: 1080-6040 [Print] United States
PMID17479892 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
Topics
  • Antibodies, Viral (blood)
  • Dengue (immunology, virology)
  • Dengue Virus (classification)
  • Humans
  • Neutralization Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: